Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Singapore National Eye Centre Neurovision Health Promotion Board, Singapore |
---|---|
Information provided by: | Singapore National Eye Centre |
ClinicalTrials.gov Identifier: | NCT00348218 |
This is a pilot study to assess the effectiveness of Neurovision treatment in the improvement of vision in childen being under-corrected and to assess the effectiveness of Neurovision treatment in slowing down myopia progression in children.
Condition | Intervention | Phase |
---|---|---|
Myopia |
Device: NeuroVision |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Pilot Stduy To Evaluate The Efficacy Of Neurovision’S NVC™- Vision Correction Technology For The Improvement In Visual Acuity In Myopic Children And Slowing Down Of Myopia Progression |
Estimated Enrollment: | 30 |
Study Start Date: | June 2006 |
Ages Eligible for Study: | 7 Years to 9 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
The subject is able and willing to attend all study sessions and visits at the required frequency:
Exclusion Criteria:
Contact: Chye Fong Peck | peck.chye.fong@seri.com.sg |
Singapore | |
Singapore Eye Research Institute | Recruiting |
Singapore, Singapore, 168751 | |
Sub-Investigator: Allan Fong, MRCOphth | |
Sub-Investigator: Seang Mei Saw, MBBS, MPH | |
Sub-Investigator: Nir Ellenbogen |
Principal Investigator: | Donald Tan, FRCS | Singapore Eye Research Institute |
Principal Investigator: | Wei Han Chua, FRCS | Singapore National Eye Centre |
Study ID Numbers: | R462/11/2006 |
Study First Received: | July 3, 2006 |
Last Updated: | July 3, 2006 |
ClinicalTrials.gov Identifier: | NCT00348218 |
Health Authority: | Singapore: Domain Specific Review Boards |
Neurovision Myopia Therapy |
Eye Diseases Disease Progression Myopia Refractive Errors |